Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110257Source: DataRank Database

Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma is a research paper published in Radiotherapy and Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.52)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Michael Farris ORCID,James D. Ververs ORCID,Ryan T. Hughes ORCID,Michael T. Munley,Feng Liu ORCID

Live enrichment

PubMed:38548113 PMC:PMC11098686 OpenAlex:https://openalex.org/W4393195680

National Institutes of Health

Grant: KL2TR001421

National Center for Advancing Translational Sciences

FWCI

0.52

Citation Percentile

0.6%

Citation Trend

2025

2026

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11098686/pdf/nihms-1988899.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0167814024001798?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814024001798?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11098686

Fields of Study

Effects of Radiation ExposureAdvanced Radiotherapy TechniquesLung Cancer Diagnosis and Treatment

MeSH Terms

Radiation Dose HypofractionationAdenocarcinoma of LungCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellFemaleHumansLung NeoplasmsMaleNeoplasm StagingRadiosurgeryDose Fractionation, Radiation

Keywords

MedicineHistologyAdenocarcinomaRadiation therapyLung cancerStage (stratigraphy)Dose fractionationLungNuclear medicineCancerRadiologyOncologyInternal medicineBiologyTumor Control ProbabilityStereotactic Body Radiation TherapyBiologically Effective DoseEarly-stage Lung Adenocarcinoma And Squamous Cell CarcinomaThe Hypofractionated Treatment Effects In The Clinic (Hytec)

Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma

FAIR Checklist

Authors (5)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)